PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is the Correlation Between Diabetes and Ischemic Events? How Effective Are Rivaroxaban and Aspirin?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is the Correlation Between Diabetes and Ischemic Events? How Effective Are Rivaroxaban and Aspirin?

By Cardiometabolic Health Congress (CMHC) FEATURING Deepak Bhatt

85 views

May 19, 2021

0 Comments

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Chest Pain in Women: CT's role in making an accurate diagnosis

Feat. L. Shaw, M. Gulati

Ambulatory Blood Pressure Monitoring

26:11

13th Orange County Symposium for Cardiovascular Disease Prevention

Update on Calcium Screening and CTA: Role in Prevention

Feat. M. Budoff

49:21

Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key

42:28

Scripps Health

CT Coronary Calcium Scoring, Hard Plaque and Soft Plaque Visualizati…

Feat. M. Budoff

59:01

The North American Thrombosis Forum (NATF)

Recent Cholesterol Guidelines and Integration into Clinical Practice

Feat. J. Plutzky, L. Braun, J. Ross

18:43

Canadian Collaborative Research Network

Lp(a): When to Measure it and What to Do About it

Feat. M. O'Donoghue

08:44

AHA 2022 Conference Coverage

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

Feat. N. Marston

14:39

Lankenau

Management of AF patients with ACS

Feat. P. Kowey, D. Ice

14:50

AHA 2022 Conference Coverage

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

Feat. K. Ray

34:20

Cedars Sinai

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Feat. J. Forrester

19:16

The Texas Heart Institute

Role of Coronary Calcification and Risk Stratification

Feat. E. Hernandez

45:45

Houston Methodist DeBakey Heart and Vascular Center

Directions of Cardiology in the Next Decade: 2022-2032

Feat. E. Braunwald

15:40

ACC 2022 Conference Coverage

ACC 2022: Triple Therapy - When to Use and How Long

Feat. D. Kumbhani

31:02

Scripps Health

How Do I Reverse Coronary Plaque?

Feat. C. J. Suhar

24:02

Complex Coronary Cases

Updated Lipid Guidelines and Therapy

Feat. I. Fergus

19:48

ACC 2022 Conference Coverage

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "…

Feat. R. Giugliano

19:24

National Lipid Association

Do Triglycerides Cause Heart Disease?

Feat. I. Goldberg

54:16

Georgia Heart Institute

Coronary Calcification: Basic Mechanisms, Research Applications, and…

Feat. K. Watson

31:27

Scripps Health

Evaluate the Horrible Cholesterol Lp(a): Prevalence, Impact and Nove…

Feat. N. Lepor

36:50

Houston Methodist DeBakey Heart and Vascular Center

Ischemic Heart Disease in Women - New Updates

Feat. L. Shaw

Login

Login

Join VuMedi

PAD in Patients with (a Risk of) Cardiometabolic Disease: What Is the Correlation Between Diabetes and Ischemic Events? How Effective Are Rivaroxaban and Aspirin?

Related Content